nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—CYP2C8—Simvastatin—atherosclerosis	0.178	0.338	CbGbCtD
Tazarotene—CYP2C8—Pravastatin—atherosclerosis	0.175	0.331	CbGbCtD
Tazarotene—CYP2C8—Lovastatin—atherosclerosis	0.175	0.331	CbGbCtD
Tazarotene—Skin hyperpigmentation—Niacin—atherosclerosis	0.00588	0.0587	CcSEcCtD
Tazarotene—Burning sensation—Niacin—atherosclerosis	0.00504	0.0503	CcSEcCtD
Tazarotene—Inflammation—Ezetimibe—atherosclerosis	0.00412	0.0411	CcSEcCtD
Tazarotene—Inflammation—Simvastatin—atherosclerosis	0.00393	0.0392	CcSEcCtD
Tazarotene—Skin discolouration—Niacin—atherosclerosis	0.00387	0.0387	CcSEcCtD
Tazarotene—Dermatitis contact—Niacin—atherosclerosis	0.00346	0.0345	CcSEcCtD
Tazarotene—Skin exfoliation—Niacin—atherosclerosis	0.00334	0.0333	CcSEcCtD
Tazarotene—Swelling—Simvastatin—atherosclerosis	0.00314	0.0313	CcSEcCtD
Tazarotene—Eczema—Simvastatin—atherosclerosis	0.00308	0.0307	CcSEcCtD
Tazarotene—Eczema—Niacin—atherosclerosis	0.00283	0.0282	CcSEcCtD
Tazarotene—Dermatitis bullous—Niacin—atherosclerosis	0.00266	0.0265	CcSEcCtD
Tazarotene—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00233	0.0233	CcSEcCtD
Tazarotene—Dry skin—Niacin—atherosclerosis	0.00233	0.0232	CcSEcCtD
Tazarotene—Dry skin—Pravastatin—atherosclerosis	0.00229	0.0229	CcSEcCtD
Tazarotene—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00229	0.0228	CcSEcCtD
Tazarotene—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00218	0.0218	CcSEcCtD
Tazarotene—Oedema peripheral—Ezetimibe—atherosclerosis	0.00198	0.0197	CcSEcCtD
Tazarotene—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00197	0.0197	CcSEcCtD
Tazarotene—RARA—Nuclear Receptors—ESR1—atherosclerosis	0.00181	0.00486	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.00181	0.00485	CbGpPWpGaD
Tazarotene—Haemoglobin—Niacin—atherosclerosis	0.00177	0.0176	CcSEcCtD
Tazarotene—Haemorrhage—Niacin—atherosclerosis	0.00176	0.0175	CcSEcCtD
Tazarotene—Erythema—Ezetimibe—atherosclerosis	0.00175	0.0174	CcSEcCtD
Tazarotene—Oedema peripheral—Niacin—atherosclerosis	0.00173	0.0173	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors—PPARG—atherosclerosis	0.00172	0.00463	CbGpPWpGaD
Tazarotene—Erythema—Simvastatin—atherosclerosis	0.00167	0.0166	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.00166	0.00447	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—PPARG—atherosclerosis	0.00165	0.00444	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—PPARG—atherosclerosis	0.00165	0.00444	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.00165	0.00442	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—AHR—atherosclerosis	0.0016	0.00429	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.00158	0.00424	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.00158	0.00424	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—MAPK8—atherosclerosis	0.00156	0.00418	CbGpPWpGaD
Tazarotene—Erythema—Niacin—atherosclerosis	0.00153	0.0153	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00152	0.00408	CbGpPWpGaD
Tazarotene—Discomfort—Lovastatin—atherosclerosis	0.0015	0.015	CcSEcCtD
Tazarotene—CYP2C8—Arachidonic acid metabolism—LTA4H—atherosclerosis	0.0015	0.00402	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.00149	0.00401	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—atherosclerosis	0.00148	0.00398	CbGpPWpGaD
Tazarotene—Discomfort—Ezetimibe—atherosclerosis	0.00147	0.0147	CcSEcCtD
Tazarotene—Pain—Rosuvastatin—atherosclerosis	0.00147	0.0146	CcSEcCtD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.00143	0.00384	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.00143	0.00384	CbGpPWpGaD
Tazarotene—Discomfort—Simvastatin—atherosclerosis	0.0014	0.014	CcSEcCtD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—MAPK8—atherosclerosis	0.0014	0.00375	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—NAMPT—atherosclerosis	0.0014	0.00375	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—atherosclerosis	0.00138	0.00371	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00136	0.00366	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—MAPK3—atherosclerosis	0.00136	0.00365	CbGpPWpGaD
Tazarotene—Oedema—Simvastatin—atherosclerosis	0.00136	0.0136	CcSEcCtD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—MAPK8—atherosclerosis	0.00134	0.0036	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—MAPK8—atherosclerosis	0.00134	0.0036	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—atherosclerosis	0.00133	0.00357	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00131	0.00351	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00131	0.00351	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—atherosclerosis	0.00127	0.00342	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—atherosclerosis	0.00127	0.00342	CbGpPWpGaD
Tazarotene—Discomfort—Pravastatin—atherosclerosis	0.00127	0.0126	CcSEcCtD
Tazarotene—Oedema—Niacin—atherosclerosis	0.00125	0.0125	CcSEcCtD
Tazarotene—Pain—Lovastatin—atherosclerosis	0.00124	0.0124	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—atherosclerosis	0.00124	0.00333	CbGpPWpGaD
Tazarotene—Oedema—Pravastatin—atherosclerosis	0.00123	0.0123	CcSEcCtD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—MAPK3—atherosclerosis	0.00122	0.00328	CbGpPWpGaD
Tazarotene—Pain—Ezetimibe—atherosclerosis	0.00122	0.0122	CcSEcCtD
Tazarotene—Pruritus—Rosuvastatin—atherosclerosis	0.00121	0.0121	CcSEcCtD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—atherosclerosis	0.00119	0.00319	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—atherosclerosis	0.00119	0.00319	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—MAPK3—atherosclerosis	0.00117	0.00314	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—MAPK3—atherosclerosis	0.00117	0.00314	CbGpPWpGaD
Tazarotene—Pain—Simvastatin—atherosclerosis	0.00116	0.0116	CcSEcCtD
Tazarotene—RARA—Adipogenesis—ADIPOQ—atherosclerosis	0.00114	0.00307	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.00113	0.00303	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.00108	0.00291	CbGpPWpGaD
Tazarotene—Rash—Rosuvastatin—atherosclerosis	0.00108	0.0108	CcSEcCtD
Tazarotene—Dermatitis—Rosuvastatin—atherosclerosis	0.00108	0.0108	CcSEcCtD
Tazarotene—Pain—Niacin—atherosclerosis	0.00107	0.0107	CcSEcCtD
Tazarotene—Pain—Pravastatin—atherosclerosis	0.00105	0.0105	CcSEcCtD
Tazarotene—Pruritus—Lovastatin—atherosclerosis	0.00103	0.0103	CcSEcCtD
Tazarotene—Pruritus—Ezetimibe—atherosclerosis	0.00101	0.0101	CcSEcCtD
Tazarotene—Pruritus—Simvastatin—atherosclerosis	0.000962	0.0096	CcSEcCtD
Tazarotene—RARA—Adipogenesis—SOCS3—atherosclerosis	0.000949	0.00255	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—ALOX5AP—atherosclerosis	0.000939	0.00252	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—ALOX15—atherosclerosis	0.000939	0.00252	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000926	0.00249	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—AKT1—atherosclerosis	0.000918	0.00246	CbGpPWpGaD
Tazarotene—Rash—Lovastatin—atherosclerosis	0.000916	0.00915	CcSEcCtD
Tazarotene—Dermatitis—Lovastatin—atherosclerosis	0.000916	0.00914	CcSEcCtD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000914	0.00245	CbGpPWpGaD
Tazarotene—Rash—Ezetimibe—atherosclerosis	0.000899	0.00897	CcSEcCtD
Tazarotene—Dermatitis—Ezetimibe—atherosclerosis	0.000898	0.00896	CcSEcCtD
Tazarotene—Pruritus—Niacin—atherosclerosis	0.000883	0.00882	CcSEcCtD
Tazarotene—Pruritus—Pravastatin—atherosclerosis	0.00087	0.00868	CcSEcCtD
Tazarotene—Rash—Simvastatin—atherosclerosis	0.000857	0.00856	CcSEcCtD
Tazarotene—Dermatitis—Simvastatin—atherosclerosis	0.000856	0.00855	CcSEcCtD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000856	0.0023	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000856	0.0023	CbGpPWpGaD
Tazarotene—RXRB—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.00085	0.00228	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—LPL—atherosclerosis	0.000846	0.00227	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000845	0.00227	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—AKT1—atherosclerosis	0.000823	0.00221	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000821	0.0022	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—ALOX5—atherosclerosis	0.000799	0.00214	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—AKT1—atherosclerosis	0.000789	0.00212	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—AKT1—atherosclerosis	0.000789	0.00212	CbGpPWpGaD
Tazarotene—Rash—Niacin—atherosclerosis	0.000787	0.00786	CcSEcCtD
Tazarotene—Dermatitis—Niacin—atherosclerosis	0.000786	0.00785	CcSEcCtD
Tazarotene—Rash—Pravastatin—atherosclerosis	0.000775	0.00774	CcSEcCtD
Tazarotene—Dermatitis—Pravastatin—atherosclerosis	0.000774	0.00773	CcSEcCtD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000751	0.00202	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—PPARA—atherosclerosis	0.000747	0.00201	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—AGT—atherosclerosis	0.000724	0.00194	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—LEP—atherosclerosis	0.000709	0.0019	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000694	0.00186	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000689	0.00185	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000661	0.00177	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—PPARG—atherosclerosis	0.000618	0.00166	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000614	0.00165	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—INS—atherosclerosis	0.000606	0.00163	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000589	0.00158	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IGF1—atherosclerosis	0.000586	0.00157	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—atherosclerosis	0.000571	0.00153	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—SERPINE1—atherosclerosis	0.000556	0.00149	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000519	0.00139	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PARP1—atherosclerosis	0.000501	0.00134	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000498	0.00134	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—ESR2—atherosclerosis	0.000474	0.00127	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000449	0.00121	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PARP1—atherosclerosis	0.000449	0.00121	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000431	0.00116	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PARP1—atherosclerosis	0.00043	0.00116	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PARP1—atherosclerosis	0.00043	0.00116	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—ESR2—atherosclerosis	0.000425	0.00114	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—GPX1—atherosclerosis	0.000424	0.00114	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—ESR2—atherosclerosis	0.000408	0.00109	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—ESR2—atherosclerosis	0.000408	0.00109	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP7A1—atherosclerosis	0.000399	0.00107	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000393	0.00106	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—STAT3—atherosclerosis	0.000379	0.00102	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000373	0.001	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP27A1—atherosclerosis	0.000369	0.00099	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000364	0.000977	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000357	0.000959	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TGFB1—atherosclerosis	0.000351	0.000943	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—atherosclerosis	0.000328	0.000881	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000323	0.000868	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000318	0.000853	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARA—atherosclerosis	0.000317	0.000852	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.00031	0.000832	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000305	0.000818	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000293	0.000788	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—ESR1—atherosclerosis	0.000287	0.000772	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARA—atherosclerosis	0.000285	0.000764	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000281	0.000755	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000278	0.000745	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARA—atherosclerosis	0.000273	0.000733	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARA—atherosclerosis	0.000273	0.000733	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HSPA1B—atherosclerosis	0.00027	0.000726	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000269	0.000723	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000266	0.000715	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—atherosclerosis	0.000265	0.000711	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARG—atherosclerosis	0.000262	0.000704	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000262	0.000704	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000258	0.000693	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—ESR1—atherosclerosis	0.000258	0.000692	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000251	0.000675	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.000249	0.00067	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—ESR1—atherosclerosis	0.000247	0.000664	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—ESR1—atherosclerosis	0.000247	0.000664	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000247	0.000662	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HSPA1B—atherosclerosis	0.000242	0.000651	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000241	0.000647	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PARP1—atherosclerosis	0.000241	0.000647	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.000236	0.000634	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARG—atherosclerosis	0.000235	0.000632	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HSPA1B—atherosclerosis	0.000232	0.000624	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HSPA1B—atherosclerosis	0.000232	0.000624	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—ESR2—atherosclerosis	0.000228	0.000613	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARG—atherosclerosis	0.000226	0.000606	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARG—atherosclerosis	0.000226	0.000606	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PARP1—atherosclerosis	0.000216	0.00058	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000214	0.000574	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000214	0.000574	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.000212	0.000569	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PARP1—atherosclerosis	0.000207	0.000556	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PARP1—atherosclerosis	0.000207	0.000556	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—ESR2—atherosclerosis	0.000205	0.00055	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.000203	0.000546	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.000203	0.000546	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—ESR2—atherosclerosis	0.000196	0.000527	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ESR2—atherosclerosis	0.000196	0.000527	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.000187	0.000503	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SIRT1—atherosclerosis	0.000184	0.000493	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.00018	0.000482	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000169	0.000454	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SIRT1—atherosclerosis	0.000165	0.000443	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTM1—atherosclerosis	0.000165	0.000442	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTM1—atherosclerosis	0.000162	0.000436	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000159	0.000427	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000159	0.000427	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SIRT1—atherosclerosis	0.000158	0.000424	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SIRT1—atherosclerosis	0.000158	0.000424	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000156	0.000419	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000153	0.000411	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARA—atherosclerosis	0.000153	0.00041	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000142	0.00038	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—ESR1—atherosclerosis	0.000138	0.000372	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARA—atherosclerosis	0.000137	0.000368	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000134	0.00036	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000134	0.00036	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000134	0.00036	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000134	0.00036	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000133	0.000356	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARA—atherosclerosis	0.000131	0.000353	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARA—atherosclerosis	0.000131	0.000353	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000128	0.000344	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARG—atherosclerosis	0.000126	0.000339	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—ESR1—atherosclerosis	0.000124	0.000333	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000123	0.00033	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—ESR1—atherosclerosis	0.000119	0.00032	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ESR1—atherosclerosis	0.000119	0.00032	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000118	0.000317	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LDLRAP1—atherosclerosis	0.000117	0.000314	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000114	0.000306	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SERPINE1—atherosclerosis	0.000114	0.000305	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARG—atherosclerosis	0.000113	0.000304	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLTP—atherosclerosis	0.00011	0.000295	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARG—atherosclerosis	0.000109	0.000292	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARG—atherosclerosis	0.000109	0.000292	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SERPINE1—atherosclerosis	0.000102	0.000274	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000102	0.000273	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000101	0.000271	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.0001	0.00027	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	9.81e-05	0.000264	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SERPINE1—atherosclerosis	9.78e-05	0.000263	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SERPINE1—atherosclerosis	9.78e-05	0.000263	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCG8—atherosclerosis	9.52e-05	0.000256	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LTA4H—atherosclerosis	9.52e-05	0.000256	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	9.4e-05	0.000252	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	8.88e-05	0.000238	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	7.91e-05	0.000212	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCG1—atherosclerosis	7.52e-05	0.000202	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MAPK3—atherosclerosis	7.4e-05	0.000199	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—FABP4—atherosclerosis	7.07e-05	0.00019	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LCAT—atherosclerosis	7.07e-05	0.00019	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA4—atherosclerosis	6.94e-05	0.000186	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP7A1—atherosclerosis	6.82e-05	0.000183	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MAPK3—atherosclerosis	6.64e-05	0.000178	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	6.5e-05	0.000175	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MAPK3—atherosclerosis	6.36e-05	0.000171	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MAPK3—atherosclerosis	6.36e-05	0.000171	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP27A1—atherosclerosis	6.31e-05	0.000169	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.21e-05	0.000167	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.06e-05	0.000163	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	5.98e-05	0.000161	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALOX15—atherosclerosis	5.98e-05	0.000161	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	5.98e-05	0.000161	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA2—atherosclerosis	5.98e-05	0.000161	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCG5—atherosclerosis	5.9e-05	0.000159	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.9e-05	0.000158	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LPA—atherosclerosis	5.7e-05	0.000153	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—BGN—atherosclerosis	5.52e-05	0.000148	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.48e-05	0.000147	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA5—atherosclerosis	5.47e-05	0.000147	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.31e-05	0.000143	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	5.26e-05	0.000141	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.2e-05	0.00014	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.16e-05	0.000138	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.14e-05	0.000138	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALOX5—atherosclerosis	5.08e-05	0.000136	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—AKT1—atherosclerosis	4.99e-05	0.000134	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.7e-05	0.000126	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NAMPT—atherosclerosis	4.56e-05	0.000122	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.53e-05	0.000122	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LIPC—atherosclerosis	4.53e-05	0.000122	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOC3—atherosclerosis	4.5e-05	0.000121	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AKT1—atherosclerosis	4.48e-05	0.00012	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LDLR—atherosclerosis	4.47e-05	0.00012	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CETP—atherosclerosis	4.37e-05	0.000117	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AKT1—atherosclerosis	4.29e-05	0.000115	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AKT1—atherosclerosis	4.29e-05	0.000115	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SCARB1—atherosclerosis	4.19e-05	0.000112	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.08e-05	0.000109	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMGCR—atherosclerosis	3.95e-05	0.000106	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.57e-05	9.57e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCA1—atherosclerosis	3.52e-05	9.46e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMOX1—atherosclerosis	3.02e-05	8.12e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOB—atherosclerosis	2.9e-05	7.77e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTM1—atherosclerosis	2.82e-05	7.56e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LPL—atherosclerosis	2.76e-05	7.42e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GPX1—atherosclerosis	2.7e-05	7.24e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CD36—atherosclerosis	2.63e-05	7.05e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTHFR—atherosclerosis	2.49e-05	6.68e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARA—atherosclerosis	2.44e-05	6.56e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AGT—atherosclerosis	2.37e-05	6.35e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOE—atherosclerosis	2.32e-05	6.22e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CAV1—atherosclerosis	2.3e-05	6.17e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA1—atherosclerosis	2.29e-05	6.15e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.09e-05	5.62e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARG—atherosclerosis	2.02e-05	5.42e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—INS—atherosclerosis	1.98e-05	5.32e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—atherosclerosis	1.81e-05	4.87e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NOS3—atherosclerosis	1.74e-05	4.66e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.59e-05	4.26e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKT1—atherosclerosis	7.98e-06	2.14e-05	CbGpPWpGaD
